New Insights in the Setting of Transplant Oncology

<i>Background and Objectives</i>: Liver transplantation (LT) is the best strategy for curing several primary and secondary hepatic malignancies. In recent years, growing interest has been observed in the enlargement of the transplant oncology indications. This paper aims to review the mo...

Full description

Bibliographic Details
Main Authors: Silvia Quaresima, Fabio Melandro, Francesco Giovanardi, Kejal Shah, Valerio De Peppo, Gianluca Mennini, Davide Ghinolfi, Ashley Limkemann, Timothy M. Pawlik, Quirino Lai
Format: Article
Language:English
Published: MDPI AG 2023-03-01
Series:Medicina
Subjects:
Online Access:https://www.mdpi.com/1648-9144/59/3/568
_version_ 1827748848385130496
author Silvia Quaresima
Fabio Melandro
Francesco Giovanardi
Kejal Shah
Valerio De Peppo
Gianluca Mennini
Davide Ghinolfi
Ashley Limkemann
Timothy M. Pawlik
Quirino Lai
author_facet Silvia Quaresima
Fabio Melandro
Francesco Giovanardi
Kejal Shah
Valerio De Peppo
Gianluca Mennini
Davide Ghinolfi
Ashley Limkemann
Timothy M. Pawlik
Quirino Lai
author_sort Silvia Quaresima
collection DOAJ
description <i>Background and Objectives</i>: Liver transplantation (LT) is the best strategy for curing several primary and secondary hepatic malignancies. In recent years, growing interest has been observed in the enlargement of the transplant oncology indications. This paper aims to review the most recent developments in the setting of LT oncology, with particular attention to LT for unresectable colorectal liver metastases (CRLM) and cholangiocellular carcinoma (CCA). <i>Materials and Methods</i>: A review of the recently published literature was conducted. <i>Results</i>: Growing evidence exists on the efficacy of LT in curing CRLM and peri-hilar and intrahepatic CCA in well-selected patients when integrating this strategy with (neo)-adjuvant chemotherapy, radiotherapy, or locoregional treatments. <i>Conclusion</i>: For unresectable CCA and CRLM management, several prospective protocols are forthcoming to elucidate LT’s impact relative to alternative therapies. Advances in diagnosis, treatment protocols, and donor-to-recipient matching are needed to better define the oncological indications for transplantation. Prospective, multicenter trials studying these advances and their impact on outcomes are still required.
first_indexed 2024-03-11T06:12:39Z
format Article
id doaj.art-c7e5e42273004555a39a26d13384b1a0
institution Directory Open Access Journal
issn 1010-660X
1648-9144
language English
last_indexed 2024-03-11T06:12:39Z
publishDate 2023-03-01
publisher MDPI AG
record_format Article
series Medicina
spelling doaj.art-c7e5e42273004555a39a26d13384b1a02023-11-17T12:32:30ZengMDPI AGMedicina1010-660X1648-91442023-03-0159356810.3390/medicina59030568New Insights in the Setting of Transplant OncologySilvia Quaresima0Fabio Melandro1Francesco Giovanardi2Kejal Shah3Valerio De Peppo4Gianluca Mennini5Davide Ghinolfi6Ashley Limkemann7Timothy M. Pawlik8Quirino Lai9General Surgery and Organ Transplantation Unit, AOU Policlinico Umberto I, Sapienza University of Rome, 00161 Rome, ItalyGeneral Surgery and Organ Transplantation Unit, AOU Policlinico Umberto I, Sapienza University of Rome, 00161 Rome, ItalyGeneral Surgery and Organ Transplantation Unit, AOU Policlinico Umberto I, Sapienza University of Rome, 00161 Rome, ItalyDepartment of Surgery, Division of Surgical Oncology, James Cancer Center, The Ohio State University, Columbus, OH 43210, USAGeneral Surgery and Organ Transplantation Unit, AOU Policlinico Umberto I, Sapienza University of Rome, 00161 Rome, ItalyGeneral Surgery and Organ Transplantation Unit, AOU Policlinico Umberto I, Sapienza University of Rome, 00161 Rome, ItalyHepatobiliary Surgery and Liver Transplantation, University of Pisa Medical School Hospital, 56124 Pisa, ItalyDepartment of Surgery, Division of Surgical Oncology, James Cancer Center, The Ohio State University, Columbus, OH 43210, USADepartment of Surgery, Division of Surgical Oncology, James Cancer Center, The Ohio State University, Columbus, OH 43210, USAGeneral Surgery and Organ Transplantation Unit, AOU Policlinico Umberto I, Sapienza University of Rome, 00161 Rome, Italy<i>Background and Objectives</i>: Liver transplantation (LT) is the best strategy for curing several primary and secondary hepatic malignancies. In recent years, growing interest has been observed in the enlargement of the transplant oncology indications. This paper aims to review the most recent developments in the setting of LT oncology, with particular attention to LT for unresectable colorectal liver metastases (CRLM) and cholangiocellular carcinoma (CCA). <i>Materials and Methods</i>: A review of the recently published literature was conducted. <i>Results</i>: Growing evidence exists on the efficacy of LT in curing CRLM and peri-hilar and intrahepatic CCA in well-selected patients when integrating this strategy with (neo)-adjuvant chemotherapy, radiotherapy, or locoregional treatments. <i>Conclusion</i>: For unresectable CCA and CRLM management, several prospective protocols are forthcoming to elucidate LT’s impact relative to alternative therapies. Advances in diagnosis, treatment protocols, and donor-to-recipient matching are needed to better define the oncological indications for transplantation. Prospective, multicenter trials studying these advances and their impact on outcomes are still required.https://www.mdpi.com/1648-9144/59/3/568peri-hilar cholangiocarcinomaintrahepatic cholangiocarcinomacolorectal liver metastasesneoadjuvant chemotherapyliver transplantation
spellingShingle Silvia Quaresima
Fabio Melandro
Francesco Giovanardi
Kejal Shah
Valerio De Peppo
Gianluca Mennini
Davide Ghinolfi
Ashley Limkemann
Timothy M. Pawlik
Quirino Lai
New Insights in the Setting of Transplant Oncology
Medicina
peri-hilar cholangiocarcinoma
intrahepatic cholangiocarcinoma
colorectal liver metastases
neoadjuvant chemotherapy
liver transplantation
title New Insights in the Setting of Transplant Oncology
title_full New Insights in the Setting of Transplant Oncology
title_fullStr New Insights in the Setting of Transplant Oncology
title_full_unstemmed New Insights in the Setting of Transplant Oncology
title_short New Insights in the Setting of Transplant Oncology
title_sort new insights in the setting of transplant oncology
topic peri-hilar cholangiocarcinoma
intrahepatic cholangiocarcinoma
colorectal liver metastases
neoadjuvant chemotherapy
liver transplantation
url https://www.mdpi.com/1648-9144/59/3/568
work_keys_str_mv AT silviaquaresima newinsightsinthesettingoftransplantoncology
AT fabiomelandro newinsightsinthesettingoftransplantoncology
AT francescogiovanardi newinsightsinthesettingoftransplantoncology
AT kejalshah newinsightsinthesettingoftransplantoncology
AT valeriodepeppo newinsightsinthesettingoftransplantoncology
AT gianlucamennini newinsightsinthesettingoftransplantoncology
AT davideghinolfi newinsightsinthesettingoftransplantoncology
AT ashleylimkemann newinsightsinthesettingoftransplantoncology
AT timothympawlik newinsightsinthesettingoftransplantoncology
AT quirinolai newinsightsinthesettingoftransplantoncology